http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020097384-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff2a8efea2afa96a4a0375964c1ef39a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb91bbd01670a8c4e3b54a341166642c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1672db5c44639875223f336436228199 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca4a245ca02465f428fb0c9b7d7312e |
| publicationDate | 2002-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020097384-A |
| titleOfInvention | A Medicament which is Effective for a Virus Having a Resistance Mutation against a Known Medicament |
| abstract | 2-amino-6-arylthiopurine phosphonate of the present invention has no toxicity such as myeloid cell growth inhibition or mutagenicity, has high antiviral activity, has oral absorptivity and stability, and is resistant to conventional antiviral agents. It is also effective against mutant viruses known to exhibit. Therefore, in the important subject of the medical field of the establishment of a treatment for hepatitis B, it is possible to provide a good solution by providing an excellent antiviral agent. |
| priorityDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 302.